Alistair Robson
Research Subjects
Research Interests
Alistair Robson has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Sean Whittaker
Skin Tumour Unit, St John's Institute of Dermatology, London, UK
4 shared publicationsStephen Morris
Skin Tumour Unit, St John's Institute of Dermatology, London, UK
3 shared publicationsTony Petrella
Department of Pathology, University of Dijon, Dijon, France
3 shared publicationsEduardo Calonje
St John's Institute of Dermatology, London, UK
2 shared publicationsFiona Child
St John's Institute of Dermatology London UK
2 shared publicationsLorenzo Cerroni
Department of Dermatology, Medical University of Graz, Graz, Austria
2 shared publications
Latest Publications
- 5 April 2017
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 15 (4) , 390-394
Die histologischen Typen der lymphomatoiden Papulose - Ein Vorschlag für die Vereinfachung des Buchstabenchaos
- 5 April 2017
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 15 (4) , 390-394
Die histologischen Typen der lymphomatoiden Papulose - Ein Vorschlag für die Vereinfachung des Buchstabenchaos
- 1 October 2015
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 43 (2) , 125-136
Indolent CD8‐positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient
Background: Primary cutaneous indolent CD8‐positive lymphoid proliferation is an emerging entity characterized by slowly enlarging papules and nodules that are pathologically comprised of clonal nonepidermotropic medium‐sized atypical CD8(+) T‐cells. Although the majority of lesions are solitary and located on the ears, bilateral symmetrical presentations have been described and lesions may arise at other peripheral or ‘acral’ sites. Patients follow a benign clinical course and systemic involvement has not yet been observed. Despite this, some medical practitioners classify such lesions as peripheral T‐cell lymphoma, NOS, a category implying aggressive disease.Objectives: We present three cases seen in our institutions and provide an update on a previously reported unique patient who continues to develop recurrent and multifocal skin lesions.Results: Systemic disease progression has not been observed, even in the presence of recurrent and multifocal cutaneous disease.Conclusions: Indolent CD8‐positive lymphoid proliferation of acral sites is a distinctive and readily identifiable entity and should be included in the next consensus revision of cutaneous lymphoma classification. Although cases described thus far have followed an indolent clinical course, dermatologists should remain guarded about the prognosis and full staging and longitudinal observation are recommended until this condition is better understood.
- 1 October 2015
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 43 (2) , 125-136
Indolent CD8‐positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient
Background: Primary cutaneous indolent CD8‐positive lymphoid proliferation is an emerging entity characterized by slowly enlarging papules and nodules that are pathologically comprised of clonal nonepidermotropic medium‐sized atypical CD8(+) T‐cells. Although the majority of lesions are solitary and located on the ears, bilateral symmetrical presentations have been described and lesions may arise at other peripheral or ‘acral’ sites. Patients follow a benign clinical course and systemic involvement has not yet been observed. Despite this, some medical practitioners classify such lesions as peripheral T‐cell lymphoma, NOS, a category implying aggressive disease.Objectives: We present three cases seen in our institutions and provide an update on a previously reported unique patient who continues to develop recurrent and multifocal skin lesions.Results: Systemic disease progression has not been observed, even in the presence of recurrent and multifocal cutaneous disease.Conclusions: Indolent CD8‐positive lymphoid proliferation of acral sites is a distinctive and readily identifiable entity and should be included in the next consensus revision of cutaneous lymphoma classification. Although cases described thus far have followed an indolent clinical course, dermatologists should remain guarded about the prognosis and full staging and longitudinal observation are recommended until this condition is better understood.
- 26 April 2014
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 41 (9) , 703-714
A review of the solitary cutaneous T‐cell lymphomas
Cutaneous T‐cell lymphomas (CTCL) account for almost 65‐92% of all cutaneous lymphomas, many of which usually present with multiple lesions. However, a number of well‐recognized and rare types of CTCL, including mycosis fungoides, can present in isolated fashion. These solitary lesions often run a relatively indolent clinical course but often pose diagnostic difficulties. We review histopathologically challenging solitary cutaneous T‐cell lymphomas, including criteria for diagnosis, clinical course and prognosis, particularly for primary cutaneous CD4+ small/medium pleomorphic lymphoma and indolent CD8+ lymphoid proliferation of acral sites. In addition, we suggest an algorithm and nomenclature to aid in the diagnosis of such problematic lesions.
- 26 April 2014
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 41 (9) , 703-714
A review of the solitary cutaneous T‐cell lymphomas
Cutaneous T‐cell lymphomas (CTCL) account for almost 65‐92% of all cutaneous lymphomas, many of which usually present with multiple lesions. However, a number of well‐recognized and rare types of CTCL, including mycosis fungoides, can present in isolated fashion. These solitary lesions often run a relatively indolent clinical course but often pose diagnostic difficulties. We review histopathologically challenging solitary cutaneous T‐cell lymphomas, including criteria for diagnosis, clinical course and prognosis, particularly for primary cutaneous CD4+ small/medium pleomorphic lymphoma and indolent CD8+ lymphoid proliferation of acral sites. In addition, we suggest an algorithm and nomenclature to aid in the diagnosis of such problematic lesions.
- 18 January 2014
- Published by Wiley in Histopathology
- Vol. 67 (4) , 425-441
Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop
Aims: Aggressive epidermotropic cutaneous CD8+ lymphoma is currently afforded provisional status in the WHO classification of lymphomas. An EORTC Workshop was convened to describe in detail the features of this putative neoplasm and evaluate its nosological status with respect to other cutaneous CD8+ lymphomas.Methods and results: Sixty‐one CD8+ cases were analysed at the workshop; clinical details, often with photographs, histological sections, immunohistochemical results, treatment and patient outcome were discussed and recorded. Eighteen cases had distinct features and conformed to the diagnosis of aggressive epidermotropic cutaneous CD8+ lymphoma. The patients typically present with widespread plaques and tumours, often ulcerated and haemorrhagic, and histologically have striking pagetoid epidermotrophism. A CD8+/CD45RA+/CD45RO−/CD2−/CD5−/CD56− phenotype, with one or more cytotoxic markers, was found in seven of 18 patients, with a very similar phenotype in the remainder. The tumours seldom involve lymph nodes, but mucosal and central nervous system involvement are not uncommon. The prognosis is poor, with a median survival of 12 months. Examples of CD8+ mycosis fungoides, lymphomatoid papulosis and Woringer–Kolopp disease presented the typical features well documented in the CD4+ forms of those diseases.Conclusions: Aggressive epidermotropic cutaneous CD8+ lymphoma is a distinct lymphoma that warrants inclusion as a distinct entity in future revisions of lymphoma classifications.
- 18 January 2014
- Published by Wiley in Histopathology
- Vol. 67 (4) , 425-441
Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop
Aims: Aggressive epidermotropic cutaneous CD8+ lymphoma is currently afforded provisional status in the WHO classification of lymphomas. An EORTC Workshop was convened to describe in detail the features of this putative neoplasm and evaluate its nosological status with respect to other cutaneous CD8+ lymphomas.Methods and results: Sixty‐one CD8+ cases were analysed at the workshop; clinical details, often with photographs, histological sections, immunohistochemical results, treatment and patient outcome were discussed and recorded. Eighteen cases had distinct features and conformed to the diagnosis of aggressive epidermotropic cutaneous CD8+ lymphoma. The patients typically present with widespread plaques and tumours, often ulcerated and haemorrhagic, and histologically have striking pagetoid epidermotrophism. A CD8+/CD45RA+/CD45RO−/CD2−/CD5−/CD56− phenotype, with one or more cytotoxic markers, was found in seven of 18 patients, with a very similar phenotype in the remainder. The tumours seldom involve lymph nodes, but mucosal and central nervous system involvement are not uncommon. The prognosis is poor, with a median survival of 12 months. Examples of CD8+ mycosis fungoides, lymphomatoid papulosis and Woringer–Kolopp disease presented the typical features well documented in the CD4+ forms of those diseases.Conclusions: Aggressive epidermotropic cutaneous CD8+ lymphoma is a distinct lymphoma that warrants inclusion as a distinct entity in future revisions of lymphoma classifications.
- 12 September 2013
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 40 (12) , 1006-1013
Evaluation of follicular T‐helper cells in primary cutaneous CD4+ small/medium pleomorphic T‐cell lymphoma and dermatitis
Background: CD4+ small/medium‐sized pleomorphic T‐cell lymphoma (SMPTCL) is a controversial primary cutaneous lymphoma, in which the candidate neoplastic cells express a follicular T‐helper phenotype. We describe 16 cases of SMPTCL and compare expression of PD‐1, CXCL‐13 and ICOS in these tumors with 40 dermatitis cases.Methods: Histopathologic examination and immunocytochemistry were performed for 16 tumors and 40 assorted dermatitis cases.Results: All but one patient presented with solitary lesions. Each biopsy revealed a dense nodular non‐epitheliotropic infiltrate of atypical T‐cells. Neoplastic cells were CD3+/CD4+/CD8(−)/CD30(−). Cutaneous recurrence occurred in one patient over a median follow up of 8 months (range 5–36). All tumors widely expressed PD‐1 and ICOS to a lesser extent. CXCL‐13 stained much fewer cells. Of the dermatitis cases, PD‐1 (most numerous) and ICOS labeled lymphoid cells in all cases, albeit fewer than in the tumors, and CXCL‐13 was negative in 32. A rosette pattern of PD‐1 expression was identified in all the SMPTCL cases but not in dermatitis.Conclusions: There remains uncertainty about the appropriate nosological status of SMPTCL, which some authors consider to be a pseudolymphoma. However, this study suggests a significant difference in the prevalence and pattern of follicular T‐helper cell markers between this tumor and lymphoid proliferations known to be reactive.
- 12 September 2013
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 40 (12) , 1006-1013
Evaluation of follicular T‐helper cells in primary cutaneous CD4+ small/medium pleomorphic T‐cell lymphoma and dermatitis
Background: CD4+ small/medium‐sized pleomorphic T‐cell lymphoma (SMPTCL) is a controversial primary cutaneous lymphoma, in which the candidate neoplastic cells express a follicular T‐helper phenotype. We describe 16 cases of SMPTCL and compare expression of PD‐1, CXCL‐13 and ICOS in these tumors with 40 dermatitis cases.Methods: Histopathologic examination and immunocytochemistry were performed for 16 tumors and 40 assorted dermatitis cases.Results: All but one patient presented with solitary lesions. Each biopsy revealed a dense nodular non‐epitheliotropic infiltrate of atypical T‐cells. Neoplastic cells were CD3+/CD4+/CD8(−)/CD30(−). Cutaneous recurrence occurred in one patient over a median follow up of 8 months (range 5–36). All tumors widely expressed PD‐1 and ICOS to a lesser extent. CXCL‐13 stained much fewer cells. Of the dermatitis cases, PD‐1 (most numerous) and ICOS labeled lymphoid cells in all cases, albeit fewer than in the tumors, and CXCL‐13 was negative in 32. A rosette pattern of PD‐1 expression was identified in all the SMPTCL cases but not in dermatitis.Conclusions: There remains uncertainty about the appropriate nosological status of SMPTCL, which some authors consider to be a pseudolymphoma. However, this study suggests a significant difference in the prevalence and pattern of follicular T‐helper cell markers between this tumor and lymphoid proliferations known to be reactive.
- 29 November 2012
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 40 (2) , 248-258
Indolent CD8+ lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features
The authors report six further cases of a cutaneous lymphoid proliferation that share many of the features of a case series previously described as indolent CD8‐positive lymphoid proliferation of the ear. Previous reports of this entity have described the slow growth of cutaneous papules and nodules, with a predilection for the ear, associated with specific histopathologic and immunophenotypic features and a benign clinical course. These include the presence of a clear Grenz zone without epidermotropism, and a CD8+ granzyme B‐ immunophenotype with a low proliferative index. The current case series presents some atypical clinical features, including site of disease beyond the ear and recurrent disease. Despite this, indolent clinical evolution is apparent. Histopathologically, three of the six cases showed a moderate‐high proliferative index, while two cases had very focal epidermotropism and Pautrier collections. A single example had significant granzyme B expression. These previously unreported features add to our understanding of this rare entity, which is not currently recognized in the World Health Organization (WHO)/European Organization for Research and Treatment of Cancer (EORTC) classification.
- 29 November 2012
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 40 (2) , 248-258
Indolent CD8+ lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features
The authors report six further cases of a cutaneous lymphoid proliferation that share many of the features of a case series previously described as indolent CD8‐positive lymphoid proliferation of the ear. Previous reports of this entity have described the slow growth of cutaneous papules and nodules, with a predilection for the ear, associated with specific histopathologic and immunophenotypic features and a benign clinical course. These include the presence of a clear Grenz zone without epidermotropism, and a CD8+ granzyme B‐ immunophenotype with a low proliferative index. The current case series presents some atypical clinical features, including site of disease beyond the ear and recurrent disease. Despite this, indolent clinical evolution is apparent. Histopathologically, three of the six cases showed a moderate‐high proliferative index, while two cases had very focal epidermotropism and Pautrier collections. A single example had significant granzyme B expression. These previously unreported features add to our understanding of this rare entity, which is not currently recognized in the World Health Organization (WHO)/European Organization for Research and Treatment of Cancer (EORTC) classification.
- 29 November 2012
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 40 (2) , 259-264
BerEP4 is widely expressed in tumors of the sweat apparatus: a source of potential diagnostic error
A 63-year-old man presented with an ulcerated nodule with a rolled pearly edge on his back. A punch biopsy showed diffuse strong BerEP4 expression and retraction artifact. Consequently the tumor was diagnosed as a basal cell carcinoma but on excision the tumor proved to be a porocarcinoma. Although Jimenez et al. reported BerEP4 expression in porocarcinoma, this result is not widely appreciated. This observation prompted us to investigate BerEP4 expression in sweat apparatus tumors. Immunocytochemistry was performed using Dako monoclonal mouse BerEP4 with Ventana Benchmark XT immunostainer. Omission of the primary antibody served as a negative control. Fourteen of 26 porocarcinomas had at least focal BerEP4 expression and two were diffusely and at least focally strongly positive. Seven of seven chondroid syringomas stained diffusely positive, with strong ductal expression; the single chondroid syringocarcinoma was negative. Five of 6 poromas and two of two hidradenomas had focal expression, and staining particularly highlighted the ducts, a co-localization also apparent in the four spiradenomas and three cylindromas. The single primary mucinous carcinoma had diffuse strong BerEP4 expression. This case and pilot study shows that BerEP4 expression is common in these selected sweat apparatus tumors, and staining may be strongly so. This observation should be borne in mind in clinical practice.
- 29 November 2012
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 40 (2) , 259-264
BerEP4 is widely expressed in tumors of the sweat apparatus: a source of potential diagnostic error
A 63-year-old man presented with an ulcerated nodule with a rolled pearly edge on his back. A punch biopsy showed diffuse strong BerEP4 expression and retraction artifact. Consequently the tumor was diagnosed as a basal cell carcinoma but on excision the tumor proved to be a porocarcinoma. Although Jimenez et al. reported BerEP4 expression in porocarcinoma, this result is not widely appreciated. This observation prompted us to investigate BerEP4 expression in sweat apparatus tumors. Immunocytochemistry was performed using Dako monoclonal mouse BerEP4 with Ventana Benchmark XT immunostainer. Omission of the primary antibody served as a negative control. Fourteen of 26 porocarcinomas had at least focal BerEP4 expression and two were diffusely and at least focally strongly positive. Seven of seven chondroid syringomas stained diffusely positive, with strong ductal expression; the single chondroid syringocarcinoma was negative. Five of 6 poromas and two of two hidradenomas had focal expression, and staining particularly highlighted the ducts, a co-localization also apparent in the four spiradenomas and three cylindromas. The single primary mucinous carcinoma had diffuse strong BerEP4 expression. This case and pilot study shows that BerEP4 expression is common in these selected sweat apparatus tumors, and staining may be strongly so. This observation should be borne in mind in clinical practice.
- 8 July 2010
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 37 (9) , 982-986
Extragenital lichen sclerosus et atrophicus mimicking cutaneous T‐cell lymphoma: report of a case
Early lesions of lichen sclerosus et atrophicus (LSA) may present as a mild lichenoid tissue reaction, occasionally together with basilar epidermotropism, mimicking early cutaneous T-cell lymphoma, mycosis fungoides (MF) variant. We report a case of extragenital LSA in which both histological patterns were present in the same clinically homogenous and stable lesion. A 27-year-old man presented with a history of white atrophic plaques on the trunk. A biopsy of an abdominal lesion revealed epidermal thinning, a superficial perivascular lymphoid cell infiltrate with focal epidermotropism, mild nuclear atypia and perinuclear halos. Immunophenotyping showed decreased CD5 and CD7, with a slight predominance of CD8-positive T-lymphocytes. All these changes were suggestive of MF. However, a repeat biopsy 3 months later from the same stable plaque revealed features diagnostic of LSA. LSA mimicking early MF histologically has been reported in genital skin. Conversely, MF may clinically and histopathologically resemble LSA. With gene rearrangement studies, clonal proliferation may not be detected in early MF but has been reported to occur in LSA. Awareness of the histopathologic spectrum of LSA within a stable plaque is important to avoid a potential diagnostic pitfall, and should prompt a repeat biopsy.
- 8 July 2010
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 37 (9) , 982-986
Extragenital lichen sclerosus et atrophicus mimicking cutaneous T‐cell lymphoma: report of a case
Early lesions of lichen sclerosus et atrophicus (LSA) may present as a mild lichenoid tissue reaction, occasionally together with basilar epidermotropism, mimicking early cutaneous T-cell lymphoma, mycosis fungoides (MF) variant. We report a case of extragenital LSA in which both histological patterns were present in the same clinically homogenous and stable lesion. A 27-year-old man presented with a history of white atrophic plaques on the trunk. A biopsy of an abdominal lesion revealed epidermal thinning, a superficial perivascular lymphoid cell infiltrate with focal epidermotropism, mild nuclear atypia and perinuclear halos. Immunophenotyping showed decreased CD5 and CD7, with a slight predominance of CD8-positive T-lymphocytes. All these changes were suggestive of MF. However, a repeat biopsy 3 months later from the same stable plaque revealed features diagnostic of LSA. LSA mimicking early MF histologically has been reported in genital skin. Conversely, MF may clinically and histopathologically resemble LSA. With gene rearrangement studies, clonal proliferation may not be detected in early MF but has been reported to occur in LSA. Awareness of the histopathologic spectrum of LSA within a stable plaque is important to avoid a potential diagnostic pitfall, and should prompt a repeat biopsy.